New study finds Sfrp1 as a potential therapeutic target in cancer treatment

Cancer is a leading cause of death globally. One of the primary reasons why cancer is such a deadly disease is the ability of cancer cells to become drug-resistant.

Related Keywords

Japan ,Yumiko Hayashi ,Hiroyasu Kidoya ,Department Of Integrative Vascular Biology ,University Of Fukui ,Professor Hiroyasu Kidoya ,Integrative Vascular Biology ,Medical Science ,Vitro Cellular ,Developmental Biology ,